Viewing nowCombinationTelmisartan 40/10 mg Tablet
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
K.S. Pharmaceutical Co., Ltd.

MFDS item code 201906301 · Approved 2019.09.04 · Insurance code 059000350
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of amlodipine or telmisartan. It helps effectively manage blood pressure, reducing the risk of cardiovascular diseases and improving health.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before treatment with this medicine. However, a direct switch to this medicine may be considered if blood pressure is not controlled with the individual components, as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Use with caution in the following patients’). In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
◦ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication may cause serious harm to the fetus when used during pregnancy, especially in the second and third trimesters, and should not be used by women who are pregnant or may become pregnant. This medication should not be administered to patients with certain conditions, and those with liver impairment, heart disease, hypotension, kidney impairment, etc., should consult a doctor before use. Before using this medication, it is necessary to check for allergic reactions or hypersensitivity, and breastfeeding women should also refrain from taking this medicine. During usage, side effects such as dizziness or peripheral edema may occur, so caution is needed if these symptoms arise. Since this medication lowers blood pressure, patients with hypotension should carefully monitor their blood pressure status while taking it. Additionally, there is a risk of hyperkalemia, so regular checks on serum potassium levels are recommended. Patients with poor kidney function should regularly undergo kidney function tests while taking this medication. Interactions may occur when used with other blood pressure medications or drugs, so it is essential to inform about any medications currently being taken. This medication may cause drowsiness or dizziness, thus care should be taken while driving or operating hazardous machinery. In the event of an overdose, severe hypotension or heart problems may occur; therefore, adherence to the prescribed dose is crucial, and immediate medical attention is required if unusual symptoms arise. The safety and efficacy of this medication have not been sufficiently established for children or adolescents under 18 years of age, and its use is not recommended. Elderly patients may be more sensitive to the medication, necessitating dose adjustments and careful monitoring.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it is best to store the medication at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer duration.
Biconvex oval double tablet in white and light gray
30 tablets/box [10 tablets/Alu-Alu X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
K.S. Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.